In addition, PRPS2 was found downregulated by the natural compound pristimerin in NSCLC cells.<h4>Conclusion</h4>PRPS2 promotes tumor growth of NSCLC through the regulation of the activation of the PI3K/AKT signaling pathway. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.